The difference in BCL2A1/BCL2L1 ratio was statistically significant not only between AML (as a whole group or divided into CR, RES and X) and ctrl, but also between RES and CR (Table 2). The gene discussed is BCL2A1; the disease is acute myeloid leukemia.